Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study.

Chantelle CarneiroRomi BloomErin IblerSara MajewskiKimberly A SableNicholas J GuidoJennifer DaySalvatore NocadelloAleksandra G FlorekDennis P WestBeatrice Nardone

Published in: Dermatologic therapy (2017)

In this population, the SI rate for biologic and nonbiologic systemic agents was clinically indistinguishable, thereby supporting consideration of the entire spectrum of available systemic therapeutic agents, both biologic and nonbiologic agents, for management of moderate to severe psoriasis.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
early onset
high intensity